Fischer Medical Ventures Ltd’s Subdued Week: -0.14% Price Change Amid Bearish Technical Signals

15 minutes ago
share
Share Via
Fischer Medical Ventures Ltd closed the week marginally lower by 0.14% at Rs.35.98, underperforming the broader Sensex which fell 1.68% over the same period. The stock experienced a volatile week marked by a fresh 52-week low, technical downgrades, and mixed momentum indicators, reflecting ongoing challenges amid a subdued market environment.

Key Events This Week

7 Sep: Stock opens at Rs.35.62, declines 1.14%

10 Sep: Technical downgrade to Sell amid bearish momentum

11 Sep: New 52-week low of Rs.31 recorded

11 Sep: Stock closes at Rs.35.98, up 3.39% intraday but weekly decline remains

Week Open
Rs.36.03
Week Close
Rs.35.98
-0.14%
Week Low
Rs.31.00
Sensex Change
-1.68%

7 September 2026: Week Opens with Decline Amid Broader Market Weakness

Fischer Medical Ventures Ltd began the week at Rs.35.62, down 1.14% from the previous Friday’s close of Rs.36.03. The decline coincided with a 0.46% drop in the Sensex to 36,218.97, reflecting a cautious market mood. Trading volume was moderate at 35,264 shares, indicating steady investor interest despite the negative price action.

8 and 9 September 2026: Continued Downtrend with Accelerating Losses

The stock extended its losses on 8 September, slipping 0.28% to Rs.35.52 on lower volume of 18,759 shares. The Sensex also declined by 0.21% to 36,144.32, maintaining the bearish market tone. On 9 September, Fischer Medical’s price fell sharply by 1.83% to Rs.34.87, with volume rising to 33,816 shares. This day marked the steepest daily drop of the week, outpacing the Sensex’s 0.62% decline to 35,921.77. The stock’s trading range remained close to its 52-week low, signalling persistent selling pressure.

10 September 2026: Technical Downgrade Spurs Bearish Momentum

On 10 September, Fischer Medical Ventures Ltd faced a technical downgrade from Hold to Sell, reflecting a shift to bearish momentum. The stock closed at Rs.34.80, down 0.20% on heavy volume of 72,960 shares. Technical indicators showed the stock trading below all key moving averages, with bearish Bollinger Bands and a negative daily trend. The Moving Average Convergence Divergence (MACD) was mildly bullish on weekly charts but bearish monthly, highlighting mixed momentum. The Relative Strength Index (RSI) remained neutral weekly but bullish monthly, suggesting some longer-term recovery potential despite short-term weakness.

Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!

  • - Recent Momentum qualifier
  • - Stellar technical indicators
  • - Large Cap fast mover

Strike Now - View Stock →

11 September 2026: New 52-Week Low Amidst Prolonged Downtrend

The stock hit a fresh 52-week low of Rs.31 on 11 September, marking a significant milestone in its ongoing decline. Despite this intraday low, Fischer Medical closed higher at Rs.35.98, gaining 3.39% on the day with volume of 36,433 shares. The broader market, however, remained weak with the Sensex falling 0.39% to 35,773.24. The stock’s weekly performance remained negative, reflecting the cumulative impact of financial pressures and technical challenges.

Financially, the company reported a 40.7% decline in Profit After Tax (PAT) to Rs.3.79 crores for the quarter ending June 2026, alongside a 12.9% drop in Profit Before Tax excluding Other Income to Rs.6.35 crores. Interest expenses surged by 361.54% to Rs.7.20 crores over six months, exerting additional strain on profitability. Despite these setbacks, Fischer Medical maintains a manageable Debt to EBITDA ratio of 2.49 times and has demonstrated strong long-term growth in net sales and operating profit at annualised rates of 283.50% and 388.62% respectively.

Technical Momentum and Market Position

The technical landscape remains complex. While weekly MACD and Know Sure Thing (KST) indicators show mild bullishness, monthly charts remain bearish. Bollinger Bands on both weekly and monthly timeframes indicate persistent downward pressure. The Relative Strength Index (RSI) is neutral weekly but bullish monthly, suggesting potential for recovery if conditions improve. On-Balance Volume (OBV) signals mild accumulation weekly but lacks clear monthly trend confirmation. The stock trades below all major moving averages, reinforcing the bearish short-term outlook.

Is Fischer Medical Ventures Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Weekly Price Performance: Fischer Medical Ventures Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-09-07 Rs.35.62 -1.14% 36,218.97 -0.46%
2026-09-08 Rs.35.52 -0.28% 36,144.32 -0.21%
2026-09-09 Rs.34.87 -1.83% 35,921.77 -0.62%
2026-09-10 Rs.34.80 -0.20% 35,912.77 -0.03%
2026-09-11 Rs.35.98 +3.39% 35,773.24 -0.39%

Key Takeaways

Positive Signals: Despite the week’s challenges, Fischer Medical Ventures Ltd showed a strong intraday recovery on 11 September, gaining 3.39%. The monthly RSI and weekly MACD indicators suggest some underlying medium-term bullish momentum. The company’s long-term growth rates in net sales and operating profit remain robust, and its manageable debt profile provides financial stability.

Cautionary Signals: The stock hit a new 52-week low of Rs.31, underscoring persistent downward pressure. Technical indicators such as Bollinger Bands and daily moving averages remain bearish, and the Mojo Grade downgrade to Sell reflects deteriorating fundamentals and technical outlook. The significant rise in interest expenses and declining profitability metrics add to near-term concerns. The stock’s weekly performance underperformed the Sensex, highlighting relative weakness.

Conclusion

Fischer Medical Ventures Ltd’s week was characterised by a delicate balance of bearish momentum and tentative signs of stabilisation. The fresh 52-week low and technical downgrade underscore ongoing challenges, while mixed momentum indicators suggest the possibility of short-term rallies amid a broader downtrend. Investors should remain cautious given the stock’s underperformance relative to the Sensex and the company’s recent financial pressures. Monitoring key technical levels and fundamental developments will be essential to assess any potential reversal or sustained recovery in the coming weeks.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News